Oxidative Stress and Redox Signalling in Parkinson’s Disease
Parkinson's Disease is the second most common neurodegenerative disorder affecting millions of people worldwide. In order to find neuroprotective strategies, a clear understanding of the mechanisms involved in the dopaminergic death of cells that progresses the disease is needed. Oxidative stress can be defined as an imbalance between the production of reactive species and the ability to detoxify them and their intermediates or by-products. Oxidative damage to lipids, proteins, and DNA has been detected in autopsies from individuals with Parkinson’s Disease and so links can be made between oxidative stress and Parkinson’s Disease pathogenesis.
This book provides a thorough review of the mechanisms by which oxidative stress and redox signalling mediate Parkinson’s Disease. Opening chapters bring readers up to speed on basic knowledge regarding oxidative stress and redox signalling, Parkinson’s Disease, and neurodegeneration before the latest advances in this field are explored in detail. Topics covered in the following chapters include the role of mitochondria, dopamine metabolism, metal homeostasis, inflammation, DNA-damage and thiol-signalling. The role of genetics and gene-environment interactions are also explored before final chapters discuss the identification of potential biomarkers for diagnosis and disease progression and the future of redox/antioxidant based therapeutics.
Written by recognized experts in the field, this book will be a valuable source of information for postgraduate students and academics, clinicians, toxicologists and risk assessment groups. Importantly, it presents the current research that might later lead to redox or antioxidant – based therapeutics for Parkinson’s disease.
Oxidative Stress and Redox Signalling in Parkinson’s Disease, The Royal Society of Chemistry, 2017.
Download citation file:
Digital access
Print format
Table of contents
-
CHAPTER 1: Etiology and Pathogenesis of Parkinson’s Diseasep1-26ByBriana R. de Miranda;Briana R. de MirandaPittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of PittsburghPittsburghPA 15260USA[email protected]Search for other works by this author on:J. Timothy GreenamyreJ. Timothy GreenamyrePittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of PittsburghPittsburghPA 15260USA[email protected]Search for other works by this author on:
-
CHAPTER 2: Oxidative Stress and Redox Signalling in the Parkinson’s Disease Brainp27-60ByPablo Hernandez-Franco;Pablo Hernandez-FrancoRedox Biology Center & School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-LincolnLincolnNE 68583USA[email protected]Search for other works by this author on:Annandurai Anandhan;Annandurai AnandhanRedox Biology Center & School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-LincolnLincolnNE 68583USA[email protected]Search for other works by this author on:Rachel M. Foguth;Rachel M. FoguthRedox Biology Center & School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-LincolnLincolnNE 68583USA[email protected]Search for other works by this author on:Rodrigo FrancoRodrigo FrancoRedox Biology Center & School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-LincolnLincolnNE 68583USA[email protected]Search for other works by this author on:
-
CHAPTER 3: Mitochondrial Dysfunction in Parkinson’s Diseasep61-96ByManisha Patel;Manisha PatelDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical CampusAuroraCO 80045USA[email protected]Search for other works by this author on:Pallavi Bhuyan McElroyPallavi Bhuyan McElroyDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical CampusAuroraCO 80045USA[email protected]Search for other works by this author on:
-
CHAPTER 4: Dopamine Metabolism and the Generation of a Reactive Aldehydep97-115ByJosephine H. Schamp;Josephine H. SchampDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, The University of IowaIowa CityIA 52242-1112USA[email protected]Search for other works by this author on:Jonathan A. DoornJonathan A. DoornDepartment of Pharmaceutical Sciences and Experimental Therapeutics, College of Pharmacy, The University of IowaIowa CityIA 52242-1112USA[email protected]Search for other works by this author on:
-
CHAPTER 5: Dopamine Oxidation and Parkinson’s Diseasep116-143ByCaitlyn W. Barrett;Caitlyn W. BarrettDepartment of Neurology, University of Pittsburgh School of MedicinePittsburghPA 15260USAPittsburgh Institute for Neurodegenerative Diseases, University of PittsburghPittsburghPA 15260USASearch for other works by this author on:Meghan L. Bucher;Meghan L. BucherPittsburgh Institute for Neurodegenerative Diseases, University of PittsburghPittsburghPA 15260USASearch for other works by this author on:Teresa G. HastingsTeresa G. HastingsDepartment of Neurology, University of Pittsburgh School of MedicinePittsburghPA 15260USAPittsburgh Institute for Neurodegenerative Diseases, University of PittsburghPittsburghPA 15260USASearch for other works by this author on:
-
CHAPTER 6: Glutathione and Thiol Redox Signalling in Parkinson’s Diseasep144-183ByMichelle Smeyne;Michelle SmeyneDepartment of Neuroscience, Vickie & Jack Farber Institute for Neuroscience, Thomas Jefferson University900 Walnut StreetPhiladelphiaPA 19107USA[email protected]Search for other works by this author on:Richard Jay SmeyneRichard Jay SmeyneDepartment of Neuroscience, Vickie & Jack Farber Institute for Neuroscience, Thomas Jefferson University900 Walnut StreetPhiladelphiaPA 19107USA[email protected]Search for other works by this author on:
-
CHAPTER 7: Neuroinflammation and Oxidative Stress in Models of Parkinson’s Disease and Protein-Misfolding Disordersp184-209ByRonald B. Tjalkens;Ronald B. TjalkensDepartment of Environmental and Radiological Health Sciences1680 Campus DeliveryFort CollinsCO 80523-1680USA[email protected]Search for other works by this author on:Karin M. Streifel;Karin M. StreifelDepartment of Environmental and Radiological Health Sciences1680 Campus DeliveryFort CollinsCO 80523-1680USA[email protected]Search for other works by this author on:Julie A. MorenoJulie A. MorenoDepartment of Microbiology, Immunology and Pathology, Colorado State University1680 Campus DeliveryFort CollinsCO 80523-1680USASearch for other works by this author on:
-
CHAPTER 8: Redox Signalling in Dopaminergic Cell Death and Survivalp210-254ByVijayalakshmi RavindranathVijayalakshmi RavindranathSearch for other works by this author on:
-
CHAPTER 9: Iron Metabolism in Parkinson’s Diseasep255-276ByGuofen Gao;Guofen GaoLaboratory of Molecular Iron Metabolism, College of Life Science, Hebei Normal UniversityShijiazhuangHebei Province050024China[email protected]Search for other works by this author on:Lin-Hao You;Lin-Hao YouLaboratory of Molecular Iron Metabolism, College of Life Science, Hebei Normal UniversityShijiazhuangHebei Province050024China[email protected]Search for other works by this author on:Yan-Zhong ChangYan-Zhong ChangLaboratory of Molecular Iron Metabolism, College of Life Science, Hebei Normal UniversityShijiazhuangHebei Province050024China[email protected]Search for other works by this author on:
-
CHAPTER 10: Protein Oxidation, Quality-Control Mechanisms and Parkinson’s Diseasep277-324ByPablo Hernandez-Franco;Pablo Hernandez-FrancoRedox Biology Center & School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-LincolnLincolnNE 68583USA[email protected]Search for other works by this author on:Annadurai Anandhan;Annadurai AnandhanRedox Biology Center & School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-LincolnLincolnNE 68583USA[email protected]Search for other works by this author on:Rodrigo FrancoRodrigo FrancoRedox Biology Center & School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-LincolnLincolnNE 68583USA[email protected]Search for other works by this author on:
-
CHAPTER 11: At the Intersection Between Mitochondrial Dysfunction and Lysosomal Autophagy: Role of PD-Related Neurotoxins and Gene Productsp325-388ByJosephat M. Asiago;Josephat M. AsiagoDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue UniversityWest LafayetteIN 47907USA[email protected]Search for other works by this author on:Trevor B. Doyle;Trevor B. DoyleDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue UniversityWest LafayetteIN 47907USA[email protected]Purdue Institute for Integrative Neuroscience, Purdue UniversityWest LafayetteIN 47907USASearch for other works by this author on:Vartika Mishra;Vartika MishraDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue UniversityWest LafayetteIN 47907USA[email protected]Search for other works by this author on:Aurélie de Rus Jacquet;Aurélie de Rus JacquetDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue UniversityWest LafayetteIN 47907USA[email protected]Search for other works by this author on:Jean-Christophe RochetJean-Christophe RochetDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue UniversityWest LafayetteIN 47907USA[email protected]Purdue Institute for Integrative Neuroscience, Purdue UniversityWest LafayetteIN 47907USASearch for other works by this author on:
-
CHAPTER 12: Genes, Aging, and Parkinson’s Diseasep389-422ByChiara Milanese;Chiara MilaneseDepartment of Genetics, Erasmus University Medical Center Rotterdam3015 CN RotterdamThe Netherlands[email protected]Fondazione Ri.MedPalermo 90133ItalySearch for other works by this author on:Pier G. MastroberardinoPier G. MastroberardinoDepartment of Genetics, Erasmus University Medical Center Rotterdam3015 CN RotterdamThe Netherlands[email protected]Search for other works by this author on:
-
CHAPTER 13: Biomarkers of Oxidative Stress in Parkinson’s Diseasep423-446ByEmilio FernándezEmilio FernándezLaboratory of Molecular Neurology and Neurophysiology (BIO127), Department of Medical Physiology and Biophysics, School of Medicine, Universidad de SevillaSevillaSpain[email protected]Search for other works by this author on:
-
CHAPTER 14: Dietary Anti-, Pro-Oxidants in the Etiology of Parkinson’s Diseasep447-504ByZeynep Sena Agim;Zeynep Sena AgimSchool of Health Sciences, Purdue UniversityWest LafayetteIN47907USA[email protected][email protected]Search for other works by this author on:Jason R. CannonJason R. CannonSchool of Health Sciences, Purdue UniversityWest LafayetteIN47907USA[email protected][email protected]Search for other works by this author on:
Spotlight
Advertisement
Advertisement